Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Purdue Pharma L.P. et al v. IMPAX Laboratories, Inc.
Case Number:
1:13-cv-00763
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 06, 2013
Purdue, Impax Settle IP Claims In OxyContin Antitrust MDL
Impax Laboratories Inc. has settled a suit alleging its proposed generic version of OxyContin infringed Purdue Pharma LP's patents for a tamper-resistant version of the painkiller, according to a consent judgment filed Friday in a suit that had been rolled into antitrust multidistrict litigation in New York federal court.
-
February 04, 2013
Purdue Sues To Block Abuse-Proof OxyContin Generics
Purdue Pharma LP and Grunenthal GmbH on Friday sued two rivals in New York federal court, alleging their planned generic versions of painkiller OxyContin infringed two patents covering a so-called abuse-proof version of the drug.